An overview of conceptual frameworks, analytical approaches of the biopsy devices market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market. Biopsy devices market is expected to grow with significant rate in the near future.
The global biopsy devices market in 2020 is estimated for more than US$ 1.4 Bn and expected to reach a value of US$ 3.3 Bn by 2028 with a significant CAGR of 6.7%.
Biopsy Devices Market Definition
A biopsy involves taking small samples from the body including from sites such as skin, organs, and other structures so that it can be examined under microscopy and for histological examinations. The biopsy may be needed in case of investigation of functional or structural abnormalities which helps diagnose the abnormal or diseased condition.
Biopsy devices are needed to perform a biopsy of a particular organ or tissue. A specific type of biopsy device is needed based on the indication or site from which the sample is to be taken. Heightening the importance of accurate diagnostic procedures for chronic diseases such as cancer drives demand for biopsy devices in the global market.
Biopsy Devices Market Dynamics
The growing incidence of cancer is the foremost factor driving the growth of the global biopsy devices market. According to Cancer Research U.K., 357,000 new cases of cancer were diagnosed in the U.K. in 2014, and the incidence rate is expected to increase by 2% every year by 2035. This growth in incidence clearly indicates the rising demand for biopsy devices in the nearest future. The market for biopsy devices is expected to witness a rapid rise due to a growing number of hospitals and diagnostic centers in emerging markets of the Asia Pacific and Latin America. The global biopsy devices market report includes market estimates and trends by device types, indication, and geography.
Besides, the growing demand for minimally invasive procedures is expected to expand the need for biopsy devices in hospitals and diagnostic centers over the forecast period of 2019-2027. According to Eurostat surgical operation and procedures statistics, the biopsy is the second most common diagnostic procedure for cancer diagnostics in Europe.
A breast biopsy is frequently performed among all types of biopsies and as per a population-based study performed by Mayo Clinic, the overall utilization rate for breast biopsy was found to be 62.6 per 10,000 women.
Biopsy Devices Market Key Players
The biopsy devices market is mainly dominated by C. R. Bard Inc., Becton, Dickinson and Company, INRAD Inc., Cook Group Incorporated, B. Braun Melsungen AG, Boston Scientific Corporation, Medtronic Inc., Devicor Medical Products, Inc., and Hologic Inc.
Biopsy Devices Market Segmentation
The global biopsy devices market is segmented on the basis of devices, indication, and region. On the basis of devices, the global biopsy devices market can be segmented into breast biopsy devices, Core needle biopsy devices, fine needle aspiration biopsy devices, gastrointestinal biopsy devices, and robotic guidance systems. On the basis of indication, the global biopsy devices market can be segmented into breast cancer, gastrointestinal cancer, cervical cancer, lung cancer, and others.
The global biopsy devices market is expected to increase at a steady CAGR over the forecast period owing to the increasing chronic diseases, geriatric population, and increase in trend for immediate relief across the healthcare receivers.
Biopsy Devices Market Regional Overview and Analysis
On the basis of region, the global biopsy devices market is segmented into six regions namely North America, Latin America, Asia Pacific, Europe, Middle East, and Africa. North America biopsy devices market is expected to be the most dominating market throughout the forecast period. The presence of key players and increasing healthcare expenditure in the region are some of the revenue-boosting factors.
MMC Overview on Biopsy Devices Market Report
The non-identical approach of Meridian Market Consultants stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort.
A research report on the Biopsy Devices market by Meridian Market Consultants is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that supports market and the factors that are acting as impedance for the growth of the market.
Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market. The report is titled as ‘Biopsy Devices Market: Opportunity Analysis and Future Assessment 2020-2028’.
Factors that are benchmarked while estimating the market
Various factors that are benchmarked while estimating the market growth includes (but not restricted to):
• New product designs and launches
• Current product compliance
• Reimbursement
• Concerns for use of Biopsy Devices
• Advantage of Biopsy Devices over other modalities
Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to take informed decision.
A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s products sales, previous growth rates and market expansion plans are considered to generate market share in the global market.
1. Global Biopsy Devices Report Overview
1.1. Introduction
1.2. Report Description
1.3. Methodology
2. Global Biopsy Devices Overview
2.1. Introduction
2.1.1. Market Definition
2.1.2. Market Taxonomy
2.2. Executive Summary
2.3. Global Biopsy Devices Snapshot
2.4. Global Biopsy Devices Size and Forecast, 2020–2028
2.4.1. Introduction
2.4.2. Market Value Forecast and Annual Growth Rate (AGR) Comparison (2020–2028)
2.5. Global Biopsy Devices Dynamics
2.5.1. Drivers
2.5.2. Restraints
2.5.3. Opportunity
2.5.4. Trends
2.6. Key Regulations
2.7. Porter’s Five Forces Model
3. Global Biopsy Devices, By Devices
3.1. Introduction
3.1.1. Annual Growth Rate Comparison, By Devices
3.1.2. BPS Analysis, By Devices
3.2. Market Revenue (US$Mn) and Volume (Units) Forecast, By Devices
3.2.1. Breast Biopsy Devices
3.2.2. Core Needle Biopsy Devices
3.2.3. Fine Needle Aspiration Biopsy Devices
3.2.4. Gastro Intestinal Biopsy Devices
3.2.5. Robotic Guidance Systems
3.3. Global Biopsy Devices Attractiveness Index, By Devices
4. Global Biopsy Devices, By Indication
4.1. Introduction
4.1.1. Annual Growth Rate Comparison, By Indication
4.1.2. BPS Analysis, By Indication
4.2. Market Revenue (US$Mn) and Volume (Units) Forecast, By Indication
4.2.1. Breast Cancer
4.2.2. Gastrointestinal Cancer
4.2.3. Cervical Cancer
4.2.4. Lung Cancer
4.2.5. Others
4.3. Global Biopsy Devices Attractiveness Index, By Indication
5. Global Biopsy Devices, By Region
5.1. Introduction
5.1.1. Annual Growth Rate Comparison, By Region
5.1.2. BPS Analysis, By Region
5.2. Market Revenue (US$Mn) and Volume (Units) Forecast, By Region
5.2.1. North America
5.2.2. Latin America
5.2.3. Europe
5.2.4. Asia Pacific
5.2.5. Middle East and Africa
5.3. Global Biopsy Devices Attractiveness Index, By Region
6. North America Biopsy Devices Analysis and Forecast, 2020–2028
6.1. Introduction
6.1.1. Annual Growth Rate Comparison, By Country
6.1.2. BPS Analysis, By Country
6.2. Market Revenue (US$Mn) and Volume (Units) Forecast, By Country
6.2.1. U.S. Biopsy Devices
6.2.2. Canada Biopsy Devices
6.3. North America Biopsy Devices, By Devices
6.3.1. Breast Biopsy Devices
6.3.2. Core Needle Biopsy Devices
6.3.3. Fine Needle Aspiration Biopsy Devices
6.3.4. Gastro Intestinal Biopsy Devices
6.3.5. Robotic Guidance Systems
6.4. North America Biopsy Devices, By Indication
6.4.1. Breast Cancer
6.4.2. Gastrointestinal Cancer
6.4.3. Cervical Cancer
6.4.4. Lung Cancer
6.4.5. Others
6.5. North America Biopsy Devices Attractiveness Index
6.5.1. By Country
6.5.2. By Devices
6.5.3. By Indication
7. Latin America Biopsy Devices Analysis and Forecast, 2020–2028
7.1. Introduction
7.1.1. Annual Growth Rate Comparison, By Country
7.1.2. BPS Analysis, By Country
7.2. Market (US$Mn) and Volume (Units) Forecast, By Country
7.2.1. Brazil Biopsy Devices
7.2.2. Mexico Biopsy Devices
7.2.3. Argentina Biopsy Devices
7.2.4. Rest of Latin America Biopsy Devices
7.3. Latin America Biopsy Devices, By Devices
7.3.1. Breast Biopsy Devices
7.3.2. Core Needle Biopsy Devices
7.3.3. Fine Needle Aspiration Biopsy Devices
7.3.4. Gastro Intestinal Biopsy Devices
7.3.5. Robotic Guidance Systems
7.4. Latin America Biopsy Devices, By Indication
7.4.1. Breast Cancer
7.4.2. Gastrointestinal Cancer
7.4.3. Cervical Cancer
7.4.4. Lung Cancer
7.4.5. Others
7.5. Latin America Biopsy Devices Attractiveness Index
7.5.1. By Country
7.5.2. By Devices
7.5.3. By Indication
8. Europe Biopsy Devices Analysis and Forecast, 2020–2028
8.1. Introduction
8.1.1. Annual Growth Rate Comparison, By Country
8.1.2. BPS Analysis, By Country
8.2. Market (US$Mn) and Volume (Units) Forecast, By Country
8.2.1. U.K. Biopsy Devices
8.2.2. Germany Biopsy Devices
8.2.3. Italy Biopsy Devices
8.2.4. France Biopsy Devices
8.2.5. Spain Biopsy Devices
8.2.6. Russia Biopsy Devices
8.2.7. Poland Biopsy Devices
8.2.8. BENELUX Biopsy Devices
8.2.9. NORDIC Biopsy Devices
8.2.10. Rest of Europe Biopsy Devices
8.3. Europe Biopsy Devices, By Devices
8.3.1. Breast Biopsy Devices
8.3.2. Core Needle Biopsy Devices
8.3.3. Fine Needle Aspiration Biopsy Devices
8.3.4. Gastro Intestinal Biopsy Devices
8.3.5. Robotic Guidance Systems
8.4. Europe Biopsy Devices, By Indication
8.4.1. Breast Cancer
8.4.2. Gastrointestinal Cancer
8.4.3. Cervical Cancer
8.4.4. Lung Cancer
8.4.5. Others
8.5. Europe Biopsy Devices Attractiveness Index
8.5.1. By Country
8.5.2. By Devices
8.5.3. By Indication
9. Asia Pacific Biopsy Devices Analysis and Forecast, 2020–2028
9.1. Introduction
9.1.1. Annual Growth Rate Comparison, By Country
9.1.2. BPS Analysis, By Country
9.2. Market (US$Mn) and Volume (Units) Forecast, By Country
9.2.1. China Biopsy Devices
9.2.2. India Biopsy Devices
9.2.3. Japan Biopsy Devices
9.2.4. Australia and New Zealand Biopsy Devices
9.2.5. South Korea Biopsy Devices
9.2.6. ASEAN Biopsy Devices
9.2.7. Rest of Asia Pacific Biopsy Devices
9.3. Asia Pacific Biopsy Devices, By Devices
9.3.1. Breast Biopsy Devices
9.3.2. Core Needle Biopsy Devices
9.3.3. Fine Needle Aspiration Biopsy Devices
9.3.4. Gastro Intestinal Biopsy Devices
9.3.5. Robotic Guidance Systems
9.4. Asia Pacific Biopsy Devices, By Indication
9.4.1. Breast Cancer
9.4.2. Gastrointestinal Cancer
9.4.3. Cervical Cancer
9.4.4. Lung Cancer
9.4.5. Others
9.5. Asia Pacific Biopsy Devices Attractiveness Index
9.5.1. By Country
9.5.2. By Devices
9.5.3. By Indication
10. Middle East Biopsy Devices, By Region
10.1. Introduction
10.1.1. Annual Growth Rate Comparison, By Country
10.1.2. BPS Analysis, By Country
10.2. Market (US$Mn) and Volume (Units) Forecast, By Country
10.2.1. GCC Countries Biopsy Devices
10.2.2. Israel Biopsy Devices
10.2.3. Oman Biopsy Devices
10.2.4. Rest of Middle East Biopsy Devices
10.3. Middle East Biopsy Devices, By Devices
10.3.1. Breast Biopsy Devices
10.3.2. Core Needle Biopsy Devices
10.3.3. Fine Needle Aspiration Biopsy Devices
10.3.4. Gastro Intestinal Biopsy Devices
10.3.5. Robotic Guidance Systems
10.4. Middle East Biopsy Devices, By Indication
10.4.1. Breast Cancer
10.4.2. Gastrointestinal Cancer
10.4.3. Cervical Cancer
10.4.4. Lung Cancer
10.4.5. Others
10.5. Middle East Biopsy Devices Attractiveness Index
10.5.1. By Country
10.5.2. By Devices
10.5.3. By Indication
11. Africa Biopsy Devices, By Region
11.1. Introduction
11.1.1. Annual Growth Rate Comparison, By Country
11.1.2. BPS Analysis, By Country
11.2. Market (US$Mn) and Volume (Units) Forecast, By Country
11.2.1. South Africa Biopsy Devices
11.2.2. Egypt Biopsy Devices
11.2.3. North Africa Biopsy Devices
11.2.4. Rest of Africa Biopsy Devices
11.3. Africa Biopsy Devices, By Devices
11.3.1. Breast Biopsy Devices
11.3.2. Core Needle Biopsy Devices
11.3.3. Fine Needle Aspiration Biopsy Devices
11.3.4. Gastro Intestinal Biopsy Devices
11.3.5. Robotic Guidance Systems
11.4. Africa Biopsy Devices, By Indication
11.4.1. Breast Cancer
11.4.2. Gastrointestinal Cancer
11.4.3. Cervical Cancer
11.4.4. Lung Cancer
11.4.5. Others
11.5. Africa Biopsy Devices Attractiveness Index
11.5.1. By Country
11.5.2. By Devices
11.5.3. By Indication
12. Recommendation
12.1. Market Strategy
13. Competitive Landscape
13.1. Competition Dashboard
13.2. List and Company Overview of Global Key Players
13.3. Company Profiles
13.3.1. C. R. Bard, Inc
13.3.1.1. Company Overview
13.3.1.2. Financial Overview
13.3.1.3. Product Portfolio
13.3.1.4. Key Developments
13.3.1.5. Business Strategies
13.3.2. Becton, Dickinson and Company
13.3.3. Cook Group Incorporated
13.3.4. Devicor Medical Products, Inc. (A Part of Leica Biosystems)
13.3.5. Argon Medical Devices, Inc.
13.3.6. B. Braun Melsungen AG
13.3.7. Cardinal Health, Inc.
13.3.8. Olympus Corporation
13.3.9. Boston Scientific Corporation
13.3.10. Fujifilm Holdings Corporation
13.3.11. Inrad, Inc.
13.3.12. Medtronic PLC
14. Acronyms
Frequently Asked Questions
What is the projected market size & Compound Annual Growth Rate (CAGR) of the market?
The global biopsy devices market in 2020 is estimated for more than US$ 1.4 Bn and expected to reach a value of US$ 3.3 Bn by 2028 with a significant CAGR of 6.7%.
What are the key factors driving the growth of market?
The growing incidence of cancer, growing number of hospitals and diagnostic centers in emerging markets of the Asia Pacific and Latin America, and the growing demand for minimally invasive procedures are some of the major factors which are expected to drive the growth of market.
What segments are covered in market report?
The global biopsy devices market is segmented on the basis of devices, indication, and region
What are the key participating players in the market?
The biopsy devices market is mainly dominated by C. R. Bard Inc., Becton, Dickinson and Company, INRAD Inc., Cook Group Incorporated, B. Braun Melsungen AG, Boston Scientific Corporation, Medtronic Inc., Devicor Medical Products, Inc., and Hologic Inc.
